Designed for controlled laboratory comparison, ARA-290 is an erythropoietin-derived peptide also known as cibinetide. Typical study questions concern innate-repair signaling, inflammatory injury models, small-fiber biology, and tissue-protective responses; no clinical outcome is implied.
Contact online support for real-time help with product selection, bulk orders, shipping, or payment.
One clear reference point for this compound, its format, and the supplied product information.
ARA-290 is used to frame controlled questions about innate-repair signaling, inflammatory injury models, small-fiber biology, and tissue-protective responses. Classified as an erythropoietin-derived peptide also known as cibinetide, it should be evaluated through assay-specific measurements rather than assumed outcomes.
Research designs commonly focus on innate-repair signaling, inflammatory injury models, small-fiber biology, and tissue-protective responses. Matched controls, confirmed material identity, and predefined endpoints are important because the strength and maturity of evidence differ across these areas.
The current working model is that it is reported to engage the heteromeric innate repair receptor formed by EPOR and CD131, favoring tissue-protective signaling without conventional erythropoietic activity. Direct engagement, downstream biomarkers, and whole-system outcomes should therefore be measured separately.
Research-use notice: Supplied for analytical and laboratory research only. Not for human consumption and not presented as medical guidance or a promise of efficacy.
Key answers before shipping, dispatch, and after-sales details.
Worldwide delivery in 8–15 days with air dispatch on business days.
Tracking provided on every order.
Invalid test results → Full refund.
Dedicated support team with clear pre- and post-payment updates.
Brazil orders require CPF/CNPJ for local tax handling.
Contact our online support for real-time communication about products, orders, shipping, payment, or bulk supply.